An in-depth look to CJ BIOSCIENCE operating, investing, and financing activities

311690 free cash flow for Q3 24 is -7.22 B KRW. For 2023, 311690 free cash flow was -30.01 B KRW and operating cash flow was -25.09 B KRW.